FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Donald Sherrard

Research Profile

Chemicals & Drugs

Procedures

Disorders

Anatomy

Bone and Bones

Concepts & Ideas

Physiology

Bone Development

Co-author Network

Publications

TOP 3
Donald J Sherrard
Renal osteodystrophy and aging.
Agnes Haris; Donald J Sherrard; G Hercz
Response to 'The low-calcium concentration of dialysate induced a marked increase of serum parathyroid hormone level in a continuous ambulatory peritoneal dialysis patient'.
Agnes Haris; Donald J Sherrard; G Hercz
Reversal of adynamic bone disease by lowering of dialysate calcium.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Donald Sherrard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Donald J Sherrard
Renal osteodystrophy and aging.
Seminars in nephrology 2009;29(6):636-42.
2007: Agnes Haris; Donald J Sherrard; G Hercz
Response to 'The low-calcium concentration of dialysate induced a marked increase of serum parathyroid hormone level in a continuous ambulatory peritoneal dialysis patient'.
Kidney international 2007;71(6):594-5.
2006: Agnes Haris; Donald J Sherrard; G Hercz
Reversal of adynamic bone disease by lowering of dialysate calcium.
Kidney international 2006;70(5):931-7.
2005: Bryan Kestenbaum; Joshua N Sampson; Kyle D Rudser; Donald J Patterson; Stephen L Seliger; Bessie Young; Donald J Sherrard; Dennis L Andress
Serum phosphate levels and mortality risk among people with chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2005;16(2):520-8.
2004: Bryan Kestenbaum; Dennis L Andress; Stephen M Schwartz; Daniel L Gillen; Stephen L Seliger; Paresh R Jadav; Donald J Sherrard; Catherine Stehman-Breen
Survival following parathyroidectomy among United States dialysis patients.
Kidney international 2004;66(5):2010-6.
2004: Bryan Kestenbaum; Stephen L Seliger; Daniel L Gillen; Haimanot Wasse; Bessie Young; Donald J Sherrard; Noel S Weiss; Catherine Stehman-Breen
Parathyroidectomy rates among United States dialysis patients: 1990-1999.
Kidney international 2004;65(1):282-8.
2003: Haimanot Wasse; Daniel L Gillen; Adrianne M Ball; Bryan Kestenbaum; Stephen L Seliger; Donald J Sherrard; Catherine Stehman-Breen
Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients.
Kidney international 2003;64(4):1455-61.
2002: Adrianne M Ball; Daniel L Gillen; Donald J Sherrard; Noel S Weiss; Scott S Emerson; Stephen L Seliger; Bryan Kestenbaum; Catherine Stehman-Breen
Risk of hip fracture among dialysis and renal transplant recipients.
JAMA : the journal of the American Medical Association 2002;288(23):3014-8.
2002: Frank Fung; Donald J Sherrard; Daniel L Gillen; Craig Wong; Bryan Kestenbaum; Stephen L Seliger; Adrianne Ball; Catherine Stehman-Breen
Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(2):307-14.
2002: Bryan Kestenbaum; Daniel L Gillen; Donald J Sherrard; Stephen L Seliger; Adrianne Ball; Catherine Stehman-Breen
Calcium channel blocker use and mortality among patients with end-stage renal disease.
Kidney international 2002;61(6):2157-64.
2002: Craig S Wong; Sangeeta R Hingorani; Daniel L Gillen; Donald J Sherrard; Sandra L Watkins; John R Brandt; Adrianne Ball; Catherine Stehman-Breen
Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease.
Kidney international 2002;61(2):630-7.
2002: Stephen L Seliger; Noel S Weiss; Daniel L Gillen; Bryan Kestenbaum; Adrianne Ball; Donald J Sherrard; Catherine Stehman-Breen
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients.
Kidney international 2002;61(1):297-304.
2001: KD Gibson; Daniel L Gillen; Michael T Caps; Ted R Kohler; Donald J Sherrard; Catherine Stehman-Breen
Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.
Journal of vascular surgery 2001;34(4):694-700.
2001: KD Gibson; Michael T Caps; Ted R Kohler; T S Hatsukami; Daniel L Gillen; M Aldassy; Donald J Sherrard; Catherine Stehman-Breen
Assessment of a policy to reduce placement of prosthetic hemodialysis access.
Kidney international 2001;59(6):2335-45.
2000: Catherine Stehman-Breen; Donald J Sherrard; AM Alem; Daniel L Gillen; S R Heckbert; Craig S Wong; Adrianne Ball; Noel S Weiss
Risk factors for hip fracture among patients with end-stage renal disease.
Kidney international 2000;58(5):2200-5.
2000: C S Wong; Debbie Gipson; Daniel L Gillen; Scott S Emerson; Thomas D Koepsell; Donald J Sherrard; Sandra L Watkins; Catherine Stehman-Breen
Anthropometric measures and risk of death in children with end-stage renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;36(4):811-9.
2000: AM Alem; Donald J Sherrard; Daniel L Gillen; Noel S Weiss; S A Beresford; S R Heckbert; C Wong; Catherine Stehman-Breen
Increased risk of hip fracture among patients with end-stage renal disease.
Kidney international 2000;58(1):396-9.
2000: Catherine Stehman-Breen; Donald J Sherrard; Daniel L Gillen; Michael T Caps
Determinants of type and timing of initial permanent hemodialysis vascular access.
Kidney international 2000;57(2):639-45.
1999: Annamaria T Kausz; J E Antonsen; G Hercz; Y Pei; Noel S Weiss; Scott S Emerson; Donald J Sherrard
Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(4):688-93.
1999: Catherine Stehman-Breen; Donald J Sherrard; A Walker; R Sadler; AM Alem; Jill Lindberg
Racial differences in bone mineral density and bone loss among end-stage renal disease patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(5):941-6.
1998: J E Antonsen; Donald J Sherrard; Dennis L Andress
A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication.
Kidney international 1998;53(1):223-7.
1997: D M Kates; Donald J Sherrard; Dennis L Andress
Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;30(6):809-13.
1997: R A Kronmal; John N Krieger; V Coxon; P Wortley; L Thompson; Donald J Sherrard
Vasectomy is associated with an increased risk for urolithiasis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(2):207-13.
1996: C Stehman-Breen; N Muirhead; D Thorning; Donald J Sherrard
Secondary hyperparathyroidism complicated by parathyromatosis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(4):502-7.
1996: John N Krieger; R A Kronmal; V Coxon; P Wortley; L Thompson; Donald J Sherrard
Dietary and behavioral risk factors for urolithiasis: potential implications for prevention.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(2):195-201.
1996: Donald J Sherrard; G Hercz; York Pei; G Segre
The aplastic form of renal osteodystrophy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 3():29-31.
1995: M Wang; G Hercz; Donald J Sherrard; N A Maloney; G V Segre; York Pei
Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(5):836-44.
1995: York Pei; G Hercz; C Greenwood; G Segre; A Manuel; C Saiphoo; S Fenton; Donald J Sherrard
Risk factors for renal osteodystrophy: a multivariant analysis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(1):149-56.
1995: Donald J Sherrard
Aplastic bone: a nondisease of medical progress.
Advances in renal replacement therapy 1995;2(1):20-3.
1993: G Hercz; York Pei; C Greenwood; A Manuel; C Saiphoo; W G Goodman; G V Segre; S Fenton; Donald J Sherrard
Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function.
Kidney international 1993;44(4):860-6.
1993: York Pei; G Hercz; C Greenwood; G Segre; A Manuel; C Saiphoo; S Fenton; Donald J Sherrard
Renal osteodystrophy in diabetic patients.
Kidney international 1993;44(1):159-64.
1993: J C Saitta; Susan M Ott; Donald J Sherrard; Carolyn Walden; EW Lipkin
Metabolic bone disease in adults receiving long-term parenteral nutrition: longitudinal study with regional densitometry and bone biopsy.
JPEN. Journal of parenteral and enteral nutrition 1993;17(3):214-9.
1993: Gordon Klein; David N Herndon; T C Rutan; Donald J Sherrard; Jack W Coburn; Craig B Langman; M L Thomas; J G Haddad; CW Cooper; N L Miller
Bone disease in burn patients.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1993;8(3):337-45.
1993: Donald J Sherrard; G Hercz; York Pei; N A Maloney; C Greenwood; A Manuel; C Saiphoo; S S Fenton; G V Segre
The spectrum of bone disease in end-stage renal failure--an evolving disorder.
Kidney international 1993;43(2):436-42.
1992: York Pei; G Hercz; C Greenwood; Donald J Sherrard; G Segre; A Manuel; C Saiphoo; S Fenton
Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients.
Kidney international 1992;41(5):1374-82.
1991: S Onishi; D L Andress; N A Maloney; Jack W Coburn; Donald J Sherrard
Beta 2-microglobulin deposition in bone in chronic renal failure.
Kidney international 1991;39(5):990-5.
1991: Gordon Klein; A C Alfrey; Moshe Shike; Donald J Sherrard
Parenteral drug products containing aluminum as an ingredient or a contaminant: response to FDA notice of intent. ASCN/ASPEN Working Group on Standards for Aluminum Content of Parenteral Nutrition Solutions.
The American journal of clinical nutrition 1991;53(2):399-402.
1990: P Langevitz; D Buskila; J Stewart; Donald J Sherrard; G Hercz
Osteonecrosis in patients receiving dialysis: report of two cases and review of the literature.
The Journal of rheumatology 1990;17(3):402-6.
1989: D L Andress; Keith C Norris; Jack W Coburn; E A Slatopolsky; Donald J Sherrard
Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
The New England journal of medicine 1989;321(5):274-9.
1989: Donald J Sherrard; N A Maloney
Single-dose tetracycline labeling for bone histomorphometry.
American journal of clinical pathology 1989;91(6):682-7.
1989: Donald J Sherrard; D L Andress
Aluminum-related osteodystrophy.
Advances in internal medicine 1989;34():307-23.
1988: Jorge H Vargas; G L Klein; Marvin E Ament; S M Ott; Donald J Sherrard; R L Horst; W E Berquist; A C Alfrey; E Slatopolsky; Jack W Coburn
Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content.
The American journal of clinical nutrition 1988;48(4):1070-8.
1988: J B Kopp; D L Andress; N A Maloney; Donald J Sherrard
Bone aluminum accumulation in hemodialysis patients: a longitudinal perspective.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;12(3):214-9.
1988: Jack W Coburn; Keith C Norris; Donald J Sherrard; M Bia; F Llach; A C Alfrey; E Slatopolsky
Toxic effects of aluminum in end-stage renal disease: discussion of a case.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;12(3):171-84.
1988: Donald J Sherrard; J V Walker; J L Boykin
Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;12(2):126-30.
1988: G Hercz; D L Andress; H G Nebeker; J H Shinaberger; Donald J Sherrard; Jack W Coburn
Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1988;11(1):70-5.
1987: C C Liu; Donald J Sherrard; N A Maloney; Guy A Howard
Reactivation of inhibited bone acid phosphatase and its significance in bone histomorphometry.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1987;35(12):1355-63.
1987: D L Andress; G Hercz; J B Kopp; D B Endres; Keith C Norris; Jack W Coburn; Donald J Sherrard
Bone histomorphometry of renal osteodystrophy in diabetic patients.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1987;2(6):525-31.
1987: D L Andress; N A Maloney; Jack W Coburn; D B Endres; Donald J Sherrard
Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
The Journal of clinical endocrinology and metabolism 1987;65(1):11-6.
1987: D L Andress; H G Nebeker; S M Ott; D B Endres; A C Alfrey; E A Slatopolsky; Jack W Coburn; Donald J Sherrard
Bone histologic response to deferoxamine in aluminum-related bone disease.
Kidney international 1987;31(6):1344-50.
1987: D L Andress; J B Kopp; N A Maloney; Jack W Coburn; Donald J Sherrard
Early deposition of aluminum in bone in diabetic patients on hemodialysis.
The New England journal of medicine 1987;316(6):292-6.
1987: S M Ott; E Feist; D L Andress; C C Liu; Donald J Sherrard; A C Alfrey; E Slatopolsky; Guy A Howard
Development and reversibility of aluminum-induced bone lesion in the rat.
The Journal of laboratory and clinical medicine 1987;109(1):40-7.
1987: G Hercz; D L Andress; Keith C Norris; J H Shinaberger; E A Slatopolsky; Donald J Sherrard; Jack W Coburn
Improved bone formation in dialysis patients after substitution of calcium carbonate for aluminum gels.
Transactions of the Association of American Physicians 1987;100():139-46.
1986: S M Ott; D L Andress; Donald J Sherrard
Bone oxalate in a long-term hemodialysis patient who ingested high doses of vitamin C.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1986;8(6):450-4.
1986: D L Andress; D B Endres; N A Maloney; J B Kopp; Jack W Coburn; Donald J Sherrard
Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.
The Journal of clinical endocrinology and metabolism 1986;63(5):1163-9.
1986: D L Andress; N A Maloney; D B Endres; Donald J Sherrard
Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1986;1(5):391-8.
1986: H G Nebeker; D L Andress; D S Milliner; S M Ott; A C Alfrey; E A Slatopolsky; Donald J Sherrard; Jack W Coburn
Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
Kidney international. Supplement 1986;18():S96-9.
1986: D L Andress; D B Endres; S M Ott; Donald J Sherrard
Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.
Kidney international. Supplement 1986;18():S87-90.
1986: S M Ott; D L Andress; H G Nebeker; D S Milliner; N A Maloney; Jack W Coburn; Donald J Sherrard
Changes in bone histology after treatment with desferrioxamine.
Kidney international. Supplement 1986;18():S108-13.
1986: G Hercz; J A Kraut; D A Andress; N Howard; C Roberts; J H Shinaberger; Donald J Sherrard; Jack W Coburn
Use of calcium carbonate as a phosphate binder in dialysis patients.
Mineral and electrolyte metabolism 1986;12(5-6):314-9.
1985: Keith C Norris; P W Crooks; H G Nebeker; G Hercz; D S Milliner; K Gerszi; E Slatopolsky; D L Andress; Donald J Sherrard; Jack W Coburn
Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1985;6(5):342-7.
1985: D L Andress; S M Ott; N A Maloney; Donald J Sherrard
Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure.
The New England journal of medicine 1985;312(8):468-73.
1984: D S Milliner; H G Nebeker; S M Ott; D L Andress; Donald J Sherrard; A C Alfrey; E A Slatopolsky; Jack W Coburn
Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.
Annals of internal medicine 1984;101(6):775-9.
1983: S M Ott; N A Maloney; Gordon Klein; A C Alfrey; Marvin E Ament; Jack W Coburn; Donald J Sherrard
Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.
Annals of internal medicine 1983;98(6):910-4.
1983: J A Kraut; J H Shinaberger; F R Singer; Donald J Sherrard; J Saxton; J H Miller; K Kurokawa; Jack W Coburn
Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia.
Kidney international 1983;23(5):725-30.
1983: A B Hodsman; E G Wong; Donald J Sherrard; A S Brickman; D B Lee; F R Singer; A W Norman; Jack W Coburn
Preliminary trials with 24,25-dihydroxyvitamin D3 in dialysis osteomalacia.
The American journal of medicine 1983;74(3):407-14.
1982: S M Ott; N A Maloney; Jack W Coburn; A C Alfrey; Donald J Sherrard
The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.
The New England journal of medicine 1982;307(12):709-13.
1982: Gordon Klein; A C Alfrey; N L Miller; Donald J Sherrard; T K Hazlet; Marvin E Ament; Jack W Coburn
Aluminum loading during total parenteral nutrition.
The American journal of clinical nutrition 1982;35(6):1425-9.
1982: A B Hodsman; Donald J Sherrard; A C Alfrey; S Ott; A S Brickman; N L Miller; N A Maloney; Jack W Coburn
Bone aluminum and histomorphometric features of renal osteodystrophy.
The Journal of clinical endocrinology and metabolism 1982;54(3):539-46.
1982: N A Maloney; S M Ott; A C Alfrey; N L Miller; Jack W Coburn; Donald J Sherrard
Histological quantitation of aluminum in iliac bone from patients with renal failure.
The Journal of laboratory and clinical medicine 1982;99(2):206-16.
1982: Gordon Klein; S M Ott; A C Alfrey; Donald J Sherrard; T K Hazlet; N L Miller; N A Maloney; W E Berquist; Marvin E Ament; Jack W Coburn
Aluminum as a factor in the bone disease of long-term parenteral nutrition.
Transactions of the Association of American Physicians 1982;95():155-64.
1981: A B Hodsman; Donald J Sherrard; E G Wong; A S Brickman; D B Lee; A C Alfrey; F R Singer; A W Norman; Jack W Coburn
Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism.
Annals of internal medicine 1981;94(5):629-37.
1980: Donald J Sherrard; Jack W Coburn; A S Brickman; F R Singer; N Maloney
Skeletal response to treatment with 1,25-dihydroxyvitamin D in renal failure.
Contributions to nephrology 1980;18():92-7.
1980: A S Brickman; Jack W Coburn; Donald J Sherrard; E G Wong; A W Norman; F R Singer
Clinical effects of 1,25-dihydroxyvitamin D3 in uremic patients with overt osteodystrophy.
Contributions to nephrology 1980;18():29-41.
1980: Jack W Coburn; Donald J Sherrard; A S Brickman; E G Wong; A W Norman; F R Singer
A skeletal mineralizing defect in dialysis patients: a syndrome resembling osteomalacia but unrelated to viatamin D.
Contributions to nephrology 1980;18():172-83.